Chesnara Plc: Fourth acquisition in two years
12 November 2026
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands at the forefront of innovation in the biotechnology sector, leveraging cutting-edge technology to revolutionize drug discovery. With a market capitalization..
Structure Therapeutics Inc. (NASDAQ: GPCR), a biopharmaceutical company headquartered in South San Francisco, is making waves in the healthcare sector with its promising pipeline of oral..
MoonLake Immunotherapeutics (NASDAQ: MLTX), a promising clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to treating inflammatory skin and joint..
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a burgeoning player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to innovative healthcare solutions. With a..
Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biotechnology company embedded in the healthcare sector, is drawing significant attention from investors with its impressive potential upside. Based..
Teladoc Health, Inc. (NYSE: TDOC), a leader in virtual healthcare services, is making waves in the healthcare sector with its innovative approach to medical care. Headquartered..
SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands out in the biotechnology sector as a company that is not only making significant strides in addressing rare diseases and..
Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, specifically within the diagnostics and research industry. Specializing in the manufacture and sale of..
For investors seeking opportunities in the healthcare sector, Biohaven Ltd. (BHVN) presents an intriguing proposition with its focus on pioneering therapies in immunology, neuroscience, and oncology...
ImmunityBio, Inc. (NASDAQ: IBRX) stands out in the biotechnology sector with its innovative approach to developing therapies that enhance the body’s natural immune response to combat..
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is capturing the attention of investors with its promising potential upside of 126.20%. As a cutting-edge player in the healthcare sector,..
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is generating significant interest among investors, thanks to its promising pipeline of novel therapies and the potential for substantial upside. As..
Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotechnology sector, renowned for its innovative approach to drug development. With a focus on harnessing the..
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a dynamic player in the biotechnology industry, has been making waves with its innovative approach to developing treatments for intractable diseases...
Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is turning heads with a forecasted potential upside of 90.64%. As a healthcare management company,..
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a leading figure in the biotechnology sector, has been making waves with its innovative approach to treating rare and neurological..
Apogee Therapeutics, Inc. (APGE) is capturing the attention of investors with its dynamic potential upside of 141.45%, highlighting significant opportunities within the high-stakes biotechnology sector. As..
Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the competitive healthcare plans sector, offering a promising investment opportunity with a potential upside of 35.99%. Based in..
Phreesia, Inc. (NYSE: PHR) is gaining traction among investors, particularly those keen on the healthcare sector’s digital transformation. With a market capitalization of $1.64 billion, the..
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the medical devices industry, is capturing investor attention with its significant potential upside. With an average..
